1. Home
  2. WWR vs DXR Comparison

WWR vs DXR Comparison

Compare WWR & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WWR

Westwater Resources Inc.

SELL

Current Price

$0.42

Market Cap

53.4M

ML Signal

SELL

Logo Daxor Corporation

DXR

Daxor Corporation

N/A

Current Price

$8.92

Market Cap

59.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WWR
DXR
Founded
1977
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.4M
59.0M
IPO Year
2006
1995

Fundamental Metrics

Financial Performance
Metric
WWR
DXR
Price
$0.42
$8.92
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$2.17
★ $20.00
AVG Volume (30 Days)
★ 683.7K
10.9K
Earning Date
11-11-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $1,446,345.00
Revenue This Year
N/A
$44,489.33
Revenue Next Year
N/A
$74.79
P/E Ratio
★ N/A
$33.83
Revenue Growth
★ N/A
N/A
52 Week Low
$0.38
$8.56
52 Week High
$1.51
$14.76

Technical Indicators

Market Signals
Indicator
WWR
DXR
Relative Strength Index (RSI) 37.85 27.06
Support Level $0.39 $8.56
Resistance Level $0.45 $12.07
Average True Range (ATR) 0.02 0.35
MACD 0.00 -0.12
Stochastic Oscillator 45.04 8.79

Price Performance

Historical Comparison
WWR
DXR

About WWR Westwater Resources Inc.

Westwater Resources Inc is an energy technology company focused on developing battery-grade natural graphite materials through a vertically integrated, mine-to-market strategy anchored by its two primary projects in Coosa County, Alabama: the Kellyton Graphite Plant and the Coosa Graphite Deposit. Westwater also holds mineral rights to explore and mine the Coosa Graphite Deposit, which Westwater anticipates will eventually provide natural graphite flake concentrate as feedstock to the Kellyton Graphite Plant.

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.

Share on Social Networks: